Stocks in play: KITS Eyecare Ltd
Is providing selected preliminary unaudited results for its second quarter ended June 30, 2024. Total revenue grew 25% year-over-year to approximately $37.5 million. Adjusted EBITDA increased year-over-year to over 3% of Revenue.. Finished the quarter with a healthy cash balance over $19.0 million. KITS Eyecare Ltd shares T.KITS are trading down $0.04 at $8.55.
Provided Content: Content provided by Baystreet. The Globe and Mail was not involved, and material was not reviewed prior to publication.